Caricamento...
In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [(18)F]flutemetamol
BACKGROUND: The purpose of the study was to evaluate the applicability of (18)F-labelled amyloid imaging positron emission tomography (PET) agent [(18)F]flutemetamol to detect changes in brain beta-amyloid (Aβ) deposition in vivo in APP23, Tg2576 and APPswe-PS1dE9 mouse models of Alzheimer's di...
Salvato in:
| Pubblicato in: | EJNMMI Res |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4412375/ https://ncbi.nlm.nih.gov/pubmed/25977876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-014-0037-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|